Nano-X Imaging (NNOX) Competitors

$1.79 +0.08 (+4.68%)

Closing price 05/13/2026 04:00 PM Eastern

Extended Trading

$1.79 0.00 (0.00%)

As of 06:33 AM Eastern

NNOX vs. KIDS, CV, DCTH, CLPT, and RXST

Should you buy Nano-X Imaging stock or one of its competitors? MarketBeat compares Nano-X Imaging with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Nano-X Imaging include OrthoPediatrics (KIDS), CapsoVision (CV), Delcath Systems (DCTH), ClearPoint Neuro (CLPT), and RxSight (RXST). These companies are all part of the "medical equipment" industry.

How does Nano-X Imaging compare to OrthoPediatrics?

Nano-X Imaging (NASDAQ:NNOX) and OrthoPediatrics (NASDAQ:KIDS) are both small-cap medical equipment companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, valuation, analyst recommendations, institutional ownership, media sentiment, earnings, profitability and dividends.

OrthoPediatrics has a net margin of -16.31% compared to Nano-X Imaging's net margin of -790.87%. OrthoPediatrics' return on equity of -7.01% beat Nano-X Imaging's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nano-X Imaging	-790.87%	-64.65%	-57.27%
OrthoPediatrics	-16.31%	-7.01%	-4.86%

21.5% of Nano-X Imaging shares are held by institutional investors. Comparatively, 69.1% of OrthoPediatrics shares are held by institutional investors. 7.7% of Nano-X Imaging shares are held by insiders. Comparatively, 32.7% of OrthoPediatrics shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Nano-X Imaging has a beta of 1.19, suggesting that its stock price is 19% more volatile than the broader market. Comparatively, OrthoPediatrics has a beta of 0.99, suggesting that its stock price is 1% less volatile than the broader market.

Nano-X Imaging currently has a consensus price target of $5.00, suggesting a potential upside of 179.33%. OrthoPediatrics has a consensus price target of $24.44, suggesting a potential upside of 37.41%. Given Nano-X Imaging's stronger consensus rating and higher possible upside, analysts clearly believe Nano-X Imaging is more favorable than OrthoPediatrics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nano-X Imaging	2 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	3 Strong Buy rating(s)	2.83
OrthoPediatrics	1 Sell rating(s)	1 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.82

OrthoPediatrics has higher revenue and earnings than Nano-X Imaging. OrthoPediatrics is trading at a lower price-to-earnings ratio than Nano-X Imaging, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nano-X Imaging	$13.02M	9.57	-$75.02M	-$1.59	N/A
OrthoPediatrics	$236.35M	1.93	-$39.65M	-$1.68	N/A

In the previous week, Nano-X Imaging had 2 more articles in the media than OrthoPediatrics. MarketBeat recorded 4 mentions for Nano-X Imaging and 2 mentions for OrthoPediatrics. OrthoPediatrics' average media sentiment score of 1.18 beat Nano-X Imaging's score of 0.79 indicating that OrthoPediatrics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Nano-X Imaging	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
OrthoPediatrics	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

OrthoPediatrics beats Nano-X Imaging on 9 of the 17 factors compared between the two stocks.

How does Nano-X Imaging compare to CapsoVision?

Nano-X Imaging (NASDAQ:NNOX) and CapsoVision (NASDAQ:CV) are both small-cap medical equipment companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, media sentiment, dividends, institutional ownership and earnings.

CapsoVision has a net margin of 0.00% compared to Nano-X Imaging's net margin of -790.87%. CapsoVision's return on equity of 0.00% beat Nano-X Imaging's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nano-X Imaging	-790.87%	-64.65%	-57.27%
CapsoVision	N/A	N/A	N/A

21.5% of Nano-X Imaging shares are owned by institutional investors. 7.7% of Nano-X Imaging shares are owned by company insiders. Comparatively, 2.3% of CapsoVision shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Nano-X Imaging currently has a consensus price target of $5.00, suggesting a potential upside of 179.33%. CapsoVision has a consensus price target of $8.50, suggesting a potential upside of 21.43%. Given Nano-X Imaging's stronger consensus rating and higher probable upside, equities research analysts clearly believe Nano-X Imaging is more favorable than CapsoVision.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nano-X Imaging	2 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	3 Strong Buy rating(s)	2.83
CapsoVision	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50

CapsoVision has higher revenue and earnings than Nano-X Imaging. CapsoVision is trading at a lower price-to-earnings ratio than Nano-X Imaging, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nano-X Imaging	$13.02M	9.57	-$75.02M	-$1.59	N/A
CapsoVision	$13.55M	25.75	-$25.32M	-$2.19	N/A

In the previous week, Nano-X Imaging had 3 more articles in the media than CapsoVision. MarketBeat recorded 4 mentions for Nano-X Imaging and 1 mentions for CapsoVision. CapsoVision's average media sentiment score of 1.87 beat Nano-X Imaging's score of 0.79 indicating that CapsoVision is being referred to more favorably in the news media.

Company	Overall Sentiment
Nano-X Imaging	Positive
CapsoVision	Very Positive

Summary

Nano-X Imaging beats CapsoVision on 8 of the 15 factors compared between the two stocks.

How does Nano-X Imaging compare to Delcath Systems?

Nano-X Imaging (NASDAQ:NNOX) and Delcath Systems (NASDAQ:DCTH) are both small-cap medical equipment companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, profitability, media sentiment, valuation, institutional ownership, earnings and dividends.

Nano-X Imaging has a beta of 1.19, indicating that its share price is 19% more volatile than the broader market. Comparatively, Delcath Systems has a beta of 0.54, indicating that its share price is 46% less volatile than the broader market.

Delcath Systems has a net margin of 0.62% compared to Nano-X Imaging's net margin of -790.87%. Delcath Systems' return on equity of 0.51% beat Nano-X Imaging's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nano-X Imaging	-790.87%	-64.65%	-57.27%
Delcath Systems	0.62%	0.51%	0.46%

Delcath Systems has higher revenue and earnings than Nano-X Imaging. Nano-X Imaging is trading at a lower price-to-earnings ratio than Delcath Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nano-X Imaging	$13.02M	9.57	-$75.02M	-$1.59	N/A
Delcath Systems	$85.23M	4.70	$2.70M	$0.01	1,161.00

21.5% of Nano-X Imaging shares are owned by institutional investors. Comparatively, 61.1% of Delcath Systems shares are owned by institutional investors. 7.7% of Nano-X Imaging shares are owned by insiders. Comparatively, 19.4% of Delcath Systems shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Nano-X Imaging currently has a consensus price target of $5.00, suggesting a potential upside of 179.33%. Delcath Systems has a consensus price target of $22.50, suggesting a potential upside of 93.80%. Given Nano-X Imaging's stronger consensus rating and higher possible upside, research analysts clearly believe Nano-X Imaging is more favorable than Delcath Systems.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nano-X Imaging	2 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	3 Strong Buy rating(s)	2.83
Delcath Systems	2 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.43

In the previous week, Delcath Systems had 15 more articles in the media than Nano-X Imaging. MarketBeat recorded 19 mentions for Delcath Systems and 4 mentions for Nano-X Imaging. Nano-X Imaging's average media sentiment score of 0.79 beat Delcath Systems' score of 0.01 indicating that Nano-X Imaging is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Nano-X Imaging	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Delcath Systems	1 Very Positive mention(s)	4 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Delcath Systems beats Nano-X Imaging on 11 of the 17 factors compared between the two stocks.

How does Nano-X Imaging compare to ClearPoint Neuro?

Nano-X Imaging (NASDAQ:NNOX) and ClearPoint Neuro (NASDAQ:CLPT) are both small-cap medical equipment companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, profitability, media sentiment, valuation, institutional ownership, earnings and dividends.

Nano-X Imaging has a beta of 1.19, indicating that its share price is 19% more volatile than the broader market. Comparatively, ClearPoint Neuro has a beta of 1.29, indicating that its share price is 29% more volatile than the broader market.

ClearPoint Neuro has a net margin of -69.08% compared to Nano-X Imaging's net margin of -790.87%. Nano-X Imaging's return on equity of -64.65% beat ClearPoint Neuro's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nano-X Imaging	-790.87%	-64.65%	-57.27%
ClearPoint Neuro	-69.08%	-122.17%	-40.69%

ClearPoint Neuro has higher revenue and earnings than Nano-X Imaging. ClearPoint Neuro is trading at a lower price-to-earnings ratio than Nano-X Imaging, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nano-X Imaging	$13.02M	9.57	-$75.02M	-$1.59	N/A
ClearPoint Neuro	$36.97M	9.89	-$25.54M	-$0.91	N/A

21.5% of Nano-X Imaging shares are owned by institutional investors. Comparatively, 30.1% of ClearPoint Neuro shares are owned by institutional investors. 7.7% of Nano-X Imaging shares are owned by insiders. Comparatively, 6.9% of ClearPoint Neuro shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Nano-X Imaging currently has a consensus price target of $5.00, suggesting a potential upside of 179.33%. ClearPoint Neuro has a consensus price target of $18.00, suggesting a potential upside of 47.66%. Given Nano-X Imaging's stronger consensus rating and higher possible upside, research analysts clearly believe Nano-X Imaging is more favorable than ClearPoint Neuro.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nano-X Imaging	2 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	3 Strong Buy rating(s)	2.83
ClearPoint Neuro	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

In the previous week, ClearPoint Neuro had 4 more articles in the media than Nano-X Imaging. MarketBeat recorded 8 mentions for ClearPoint Neuro and 4 mentions for Nano-X Imaging. Nano-X Imaging's average media sentiment score of 0.79 beat ClearPoint Neuro's score of 0.04 indicating that Nano-X Imaging is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Nano-X Imaging	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
ClearPoint Neuro	0 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

ClearPoint Neuro beats Nano-X Imaging on 10 of the 17 factors compared between the two stocks.

How does Nano-X Imaging compare to RxSight?

RxSight (NASDAQ:RXST) and Nano-X Imaging (NASDAQ:NNOX) are both small-cap medical equipment companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, analyst recommendations, earnings, valuation, institutional ownership, dividends, media sentiment and profitability.

RxSight has a net margin of -36.58% compared to Nano-X Imaging's net margin of -790.87%. RxSight's return on equity of -17.01% beat Nano-X Imaging's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
RxSight	-36.58%	-17.01%	-15.12%
Nano-X Imaging	-790.87%	-64.65%	-57.27%

RxSight has higher revenue and earnings than Nano-X Imaging. RxSight is trading at a lower price-to-earnings ratio than Nano-X Imaging, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
RxSight	$134.48M	1.71	-$38.94M	-$1.13	N/A
Nano-X Imaging	$13.02M	9.57	-$75.02M	-$1.59	N/A

RxSight has a beta of 1.24, indicating that its share price is 24% more volatile than the broader market. Comparatively, Nano-X Imaging has a beta of 1.19, indicating that its share price is 19% more volatile than the broader market.

RxSight presently has a consensus price target of $9.44, indicating a potential upside of 70.17%. Nano-X Imaging has a consensus price target of $5.00, indicating a potential upside of 179.33%. Given Nano-X Imaging's stronger consensus rating and higher possible upside, analysts clearly believe Nano-X Imaging is more favorable than RxSight.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
RxSight	3 Sell rating(s)	10 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	1.93
Nano-X Imaging	2 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	3 Strong Buy rating(s)	2.83

In the previous week, RxSight had 5 more articles in the media than Nano-X Imaging. MarketBeat recorded 9 mentions for RxSight and 4 mentions for Nano-X Imaging. Nano-X Imaging's average media sentiment score of 0.79 beat RxSight's score of 0.01 indicating that Nano-X Imaging is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
RxSight	0 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Nano-X Imaging	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

78.8% of RxSight shares are held by institutional investors. Comparatively, 21.5% of Nano-X Imaging shares are held by institutional investors. 10.1% of RxSight shares are held by insiders. Comparatively, 7.7% of Nano-X Imaging shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

RxSight beats Nano-X Imaging on 11 of the 17 factors compared between the two stocks.

Get Nano-X Imaging News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NNOX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

NNOX vs. The Competition

Export

Metric	Nano-X Imaging	Technology Services Industry	Business Sector	NASDAQ Exchange
Market Cap	$119M	$3.78B	$6.43B	$12.20B
Dividend Yield	N/A	2.14%	3.12%	5.30%
P/E Ratio	-1.13	55.94	31.75	25.58
Price / Sales	9.57	55.52	435.73	78.80
Price / Cash	N/A	40.33	23.44	55.34
Price / Book	0.89	5.52	6.62	6.66
Net Income	-$75.02M	$31.15M	$200.59M	$333.63M
7 Day Performance	1.70%	0.93%	-1.24%	-0.12%
1 Month Performance	-27.53%	3.27%	0.74%	3.93%
1 Year Performance	-68.09%	34.49%	35.64%	36.07%

Nano-X Imaging Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
NNOX Nano-X Imaging	3.4335 of 5 stars	$1.79 +4.7%	$5.00 +179.3%	-68.7%	$119M	$13.02M	N/A	190
KIDS OrthoPediatrics	3.5741 of 5 stars	$15.78 +1.0%	$24.44 +54.9%	-23.4%	$401.48M	$236.35M	N/A	200	Gap Up
CV CapsoVision	1.522 of 5 stars	$7.07 -5.7%	$8.50 +20.2%	N/A	$373.87M	$13.55M	N/A	90
DCTH Delcath Systems	2.2019 of 5 stars	$11.02 +2.0%	$22.50 +104.2%	-24.1%	$372.11M	$85.23M	157.43	60	Earnings Report Analyst Downgrade Analyst Revision
CLPT ClearPoint Neuro	2.0879 of 5 stars	$11.18 -1.7%	$14.50 +29.7%	-14.2%	$340.94M	$36.97M	N/A	110	News Coverage Earnings Report

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:NNOX) was last updated on 5/14/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Nano-X Imaging (NNOX) Competitors

NNOX vs. KIDS, CV, DCTH, CLPT, and RXST

How does Nano-X Imaging compare to OrthoPediatrics?

Summary

How does Nano-X Imaging compare to CapsoVision?

Summary

How does Nano-X Imaging compare to Delcath Systems?

Summary

How does Nano-X Imaging compare to ClearPoint Neuro?

Summary

How does Nano-X Imaging compare to RxSight?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NNOX vs. The Competition

Nano-X Imaging Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Nano-X Imaging (NNOX) Competitors

NNOX vs. KIDS, CV, DCTH, CLPT, and RXST

How does Nano-X Imaging compare to OrthoPediatrics?

Is NNOX or KIDS more profitable?

Do insiders and institutionals hold more shares of NNOX or KIDS?

Which has more risk and volatility, NNOX or KIDS?

Do analysts recommend NNOX or KIDS?

Which has preferable valuation and earnings, NNOX or KIDS?

Does the media prefer NNOX or KIDS?

Summary

How does Nano-X Imaging compare to CapsoVision?

Is NNOX or CV more profitable?

Do insiders and institutionals hold more shares of NNOX or CV?

Do analysts recommend NNOX or CV?

Which has preferable earnings & valuation, NNOX or CV?

Does the media refer more to NNOX or CV?

Summary

How does Nano-X Imaging compare to Delcath Systems?

Which has more volatility and risk, NNOX or DCTH?

Is NNOX or DCTH more profitable?

Which has better earnings and valuation, NNOX or DCTH?

Do institutionals and insiders hold more shares of NNOX or DCTH?

Do analysts prefer NNOX or DCTH?

Does the media prefer NNOX or DCTH?

Summary

How does Nano-X Imaging compare to ClearPoint Neuro?

Which has more volatility and risk, NNOX or CLPT?

Is NNOX or CLPT more profitable?

Which has better earnings and valuation, NNOX or CLPT?

Do institutionals and insiders hold more shares of NNOX or CLPT?

Do analysts prefer NNOX or CLPT?

Does the media prefer NNOX or CLPT?

Summary

How does Nano-X Imaging compare to RxSight?

Is RXST or NNOX more profitable?

Which has better valuation and earnings, RXST or NNOX?

Which has more risk & volatility, RXST or NNOX?

Do analysts recommend RXST or NNOX?

Does the media favor RXST or NNOX?

Do insiders & institutionals hold more shares of RXST or NNOX?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NNOX vs. The Competition

Nano-X Imaging Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools